214 related articles for article (PubMed ID: 10477400)
1. Tumor necrosis factor-alpha and its soluble receptors in plasma and cerebrospinal fluid of multiple sclerosis patients treated with methylprednisolone.
Franciotta D; Bergamaschi R; Martino G; Zardini E; Desina G; Cosi V
Eur Cytokine Netw; 1999 Sep; 10(3):431-6. PubMed ID: 10477400
[TBL] [Abstract][Full Text] [Related]
2. Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis.
Scalabrino G; Galimberti D; Mutti E; Scalabrini D; Veber D; De Riz M; Bamonti F; Capello E; Mancardi GL; Scarpini E
Brain Res; 2010 May; 1333():64-71. PubMed ID: 20347721
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis.
Franciotta DM; Grimaldi LM; Martino GV; Piccolo G; Bergamaschi R; Citterio A; Melzi d'Eril GV
Ann Neurol; 1989 Dec; 26(6):787-9. PubMed ID: 2604386
[TBL] [Abstract][Full Text] [Related]
4. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis.
Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA
Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029
[TBL] [Abstract][Full Text] [Related]
5. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis.
Sharief MK; Hentges R
N Engl J Med; 1991 Aug; 325(7):467-72. PubMed ID: 1852181
[TBL] [Abstract][Full Text] [Related]
6. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production.
Braun N; Michel U; Ernst BP; Metzner R; Bitsch A; Weber F; Rieckmann P
Neurosci Lett; 1996 Sep; 215(2):75-8. PubMed ID: 8887999
[TBL] [Abstract][Full Text] [Related]
7. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
[TBL] [Abstract][Full Text] [Related]
8. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.
Akassoglou K; Bauer J; Kassiotis G; Pasparakis M; Lassmann H; Kollias G; Probert L
Am J Pathol; 1998 Sep; 153(3):801-13. PubMed ID: 9736029
[TBL] [Abstract][Full Text] [Related]
9. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Chowdhury SA; Lin J; Sadiq SA
Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
[TBL] [Abstract][Full Text] [Related]
10. Expression of costimulatory molecules and cytokines in CSF and peripheral blood mononuclear cells from multiple sclerosis patients.
Monteyne P; Van Antwerpen MP; Sindic CJ
Acta Neurol Belg; 1999 Mar; 99(1):11-20. PubMed ID: 10218088
[TBL] [Abstract][Full Text] [Related]
11. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity.
Carrieri PB; Provitera V; De Rosa T; Tartaglia G; Gorga F; Perrella O
Immunopharmacol Immunotoxicol; 1998 Aug; 20(3):373-82. PubMed ID: 9736442
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis.
Chofflon M; Juillard C; Juillard P; Gauthier G; Grau GE
Eur Cytokine Netw; 1992; 3(6):523-31. PubMed ID: 1296800
[TBL] [Abstract][Full Text] [Related]
14. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
Sellebjerg F; Börnsen L; Khademi M; Krakauer M; Olsson T; Frederiksen JL; Sørensen PS
Neurology; 2009 Dec; 73(23):2003-10. PubMed ID: 19996075
[TBL] [Abstract][Full Text] [Related]
15. Further observations on the fetal inflammatory response syndrome: a potential homeostatic role for the soluble receptors of tumor necrosis factor alpha.
Romero R; Maymon E; Pacora P; Gomez R; Mazor M; Yoon BH; Berry SM
Am J Obstet Gynecol; 2000 Nov; 183(5):1070-7. PubMed ID: 11084543
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy.
Silveira RC; Procianoy RS
J Pediatr; 2003 Nov; 143(5):625-9. PubMed ID: 14615734
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha levels in serum and cerebrospinal fluid of patients with AIDS.
Franciotta DM; Melzi d'Eril GL; Bono G; Brustia R; Ruberto G; Pagani I
Funct Neurol; 1992; 7(1):35-8. PubMed ID: 1582576
[TBL] [Abstract][Full Text] [Related]
18. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
Moreira MA; Tilbery CP; Monteiro LP; Teixeira MM; Teixeira AL
Acta Neurol Scand; 2006 Aug; 114(2):109-13. PubMed ID: 16867033
[TBL] [Abstract][Full Text] [Related]
19. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
[TBL] [Abstract][Full Text] [Related]
20. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
